|
JP2020066579A
|
|
Protracted gelation composition
|
|
JP2018108093A
|
|
Gel composition having improved physical property, and method for improving gel physical property
|
|
JP2018131403A
|
|
Hydrous pharmaceutical preparation of minodronic acid
|
|
JP2018044920A
|
|
Reagent composition for immunochromatography
|
|
WO2017038732A1
|
|
Water-containing pharmaceutical formulation of montelukast
|
|
JP2017173009A
|
|
Immunochromatography examination cassette
|
|
WO2015064680A1
|
|
Pharmaceutical composition in easy-to-take jelly form
|
|
JP2015044758A
|
|
Gel composition having improved physical properties and method for improving physical properties of gel
|
|
JP2016027003A
|
|
Long-term stable aqueous pharmaceutical formulation of olanzapine
|
|
JP2013163170A
|
|
Method for producing mixed liquid, method for producing oral jelly medicine using the method, and apparatus for producing the mixed liquid
|
|
JP2012130554A
|
|
Feeder
|
|
JP2010173993A
|
|
Orally administrable jelly pharmaceutical formulation with pharmaceutical ingredient stabilized over long period of time
|
|
JP2008308417A
|
|
Medicinal composition of antimycotic agent
|
|
JP2008260708A
|
|
Oral jelly-like pharmaceutical composition containing benzisoxazole derivative
|
|
JP2008195622A
|
|
Novel catechin derivative and use therefor
|
|
JP2008037804A
|
|
Jelly medicine extemporaneously prepared
|
|
JP2005194216A
|
|
Composition for ameliorating hepatopathy derived from allium ampeloprasum
|
|
JP2004097114A
|
|
Dried product of jelly
|
|
JP2004043333A
|
|
Swallowing auxiliary
|
|
US6521257B1
|
|
Gelled compositions
|
